Insider Transactions in Q3 2021 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2021
|
Jonathan Slonin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+15.95%
|
-
|
|
Aug 03
2021
|
Roy Winston Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+12.06%
|
-
|
|
Jul 29
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
90
-0.68%
|
$5,400
$60.81 P/Share
|
|
Jul 29
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
90
+0.68%
|
$900
$10.81 P/Share
|
|
Jul 28
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
2,410
-15.49%
|
$144,600
$60.85 P/Share
|
|
Jul 28
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
2,410
+13.41%
|
$24,100
$10.81 P/Share
|
|
Jul 02
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
421
-2.35%
|
$24,839
$59.76 P/Share
|